Difference between revisions of "Chikuma S, et al. Cancer Sci. (2017) cited as Ref 311 in DOI: 10.1038/s41392-020-0110-5 (Q9574)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Volume (P103): 108, #quickstatements; #temporary_batch_1590009084631)
(‎Created claim: Fourth Author string (P152): Yoshimura A, #quickstatements; #temporary_batch_1590155310798)
 
(2 intermediate revisions by the same user not shown)
Property / title
 +
Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy (English)
Property / title: Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy (English) / rank
 +
Normal rank
Property / Page(s)
 +
574-580
Property / Page(s): 574-580 / rank
 +
Normal rank
Property / Fourth Author string
 +
Yoshimura A
Property / Fourth Author string: Yoshimura A / rank
 +
Normal rank

Latest revision as of 13:49, 22 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Chikuma S, et al. Cancer Sci. (2017) cited as Ref 311 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Chikuma S
    0 references
    Kanamori M
    0 references
    Mise-Omata S
    0 references
    0 references
    2017
    0 references
    Cancer Sci.
    0 references
    108
    0 references
    Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy (English)
    0 references
    574-580
    0 references
    Yoshimura A
    0 references